Development of novel treatment for GVHD following hematopoietic cell transplantation using M2 macrophage
Project/Area Number |
26461443
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Hematology
|
Research Institution | Mie University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
岩本 彰太郎 三重大学, 医学系研究科, 助教 (20456734)
|
Co-Investigator(Renkei-kenkyūsha) |
TOYODA Hidemi 三重大学, 医学部附属病院, 講師 (60525327)
|
Research Collaborator |
HANAKI Ryo 三重大学, 医学部附属病院, 医員 (40780408)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 移植片対宿主病 / マクロファージ / 単球 / 造血細胞移植 / GVHD / ELISPOT法 / 慢性GVHD / 炎症性単球 / 抗炎症性単球 / 免疫組織染色法 / フローサイトメーター / 抗炎症性マクロファージ |
Outline of Final Research Achievements |
Treatment of chronic GVHD, which influences prognosis after hematopoietic cell transplantation, has not yet been established. We have previously demonstrated that anti-inflammatory monocytes produce IL-10 in chronic GVHD and are involved in the repair of damaged target organs. There are inflammatory M1 type and anti - inflammatory type M2 type in macrophages. Using this M2 macrophage, a novel treatment for GVHD has developed. Two types of macrophages M1 and M2 were induced by culturing them with cytokines of GM-CSF and M-CSF from mouse bone marrow cells. In murine GVHD model, M2 macrophages reduced lethal GVHD and improved survival rate. Future clinical application has been expected.
|
Report
(4 results)
Research Products
(11 results)
-
[Journal Article] Ewing Sarcoma of the Bone With EWS/FLI1 Translocation After Successful Treatment of Primary Osteosarcoma2017
Author(s)
Yodoya, N. Iwamoto, S. Matsumine, A. Azuma, E. Toyoda, H. Miura, Y. Nakatani, K. Imai, H. Hirayama, M. Komada, Y.
-
Journal Title
J Pediatr Hematol Oncol
Volume: 39
Issue: 1
Pages: 6-9
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Disease Recurrence After Early Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome With Complement C3 I1157T Mutation.2016
Author(s)
Toyoda, H., Wada, H., Miyata, T., Amano, K., Kihira, K., Iwamoto, S., Hirayama, M., Komada, Y.
-
Journal Title
J Pediatr Hematol Oncol
Volume: 38
Issue: 3
Pages: e137-e139
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
-
-
-